Topical gabapentin in the treatment of localized and generalized vulvodynia

Obstetrics and Gynecology

Volumn 112, Issue 3, 2008, Pages 579-585

  Boardman, Lori A ^a   Cooper, Amy S ^b   Blais, Leo R ^b   Raker, Christina A ^b  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; GABAPENTIN; LIDOCAINE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; APPLICATION SITE IRRITATION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEEDBACK SYSTEM; FEMALE; HUMAN; PAIN ASSESSMENT; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SOMNOLENCE; STUDENT T TEST; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION; URINE RETENTION; VISUAL ANALOG SCALE; VULVODYNIA; CLINICAL TRIAL; PAIN; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VULVA DISEASE;

ADMINISTRATION, TOPICAL; ADULT; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; PAIN; TREATMENT OUTCOME; VULVAR DISEASES;

EID: 55949112490     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181827c77     Document Type: Article

References (28)

1. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003; 58:82-8.
2. Meana M, Binik YM, Khalifé S, Cohen D. Dyspareunia: sexual dysfunction or pain syndrome? J Nerv Ment Dis 1997;185: 561-9.
3. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001;185:545-50.
4. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004;49:772-7.
5. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
6. Bachmann GA, Rosen R, Pinn VW, Utian WH, Ayers C, Basson R, et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006; 51:447-56.
7. ACOG Committee on Gynecologic Practice. ACOG Committee Opinion: Number 345, October 2006: vulvodynia. Obstet Gynecol 2006;108:1049-52.
8. Lundqvist EN, Hofer PA, Olofsson JI, Sjoberg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 1997;77:319-22.
9. Chadha S, Gianotten WL, Drogendijk AC, Weijmar Schultz WC, Blindeman LA, van der Meijden WI. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 1998;17: 7-11.
10. Foster DC, Piekarz KH, Murant TI, LaPoint R, Haidaris CG, Phipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibulitis fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol 2007;196:346.e1-8.
11. Weström LV, Willén R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998;91:572-6.
12. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.
13. Bornstein J, Zarfati D, Goldik Z, Abramovici H. Perineoplasty compared with vestibuloplasty for severe vulvar vestibulitis. Br J Obstet Gynaecol 1995;102:652-5.
14. Updike GM, Wiesenfeld HC. Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol 2005;193:1404-9.
15. Pagano R. Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia. Aust N Z J Obstet Gynaecol 1999;39:79-83.
16. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Derm 2003;42:491-5.
17. Reed BD, Caron AM, Gorenflo DW, Haefner HK. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis 2006;10:245-51.
18. van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004;172:533-6.
19. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. J Clin Pharmacol 2000;49:574-9.
20. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect 2001;77:53-7.
21. Walsh KE, Berman JR, Berman LA, Vierregger K. Safety and efficacy of topical nitroglycerin for treatment of vulvar pain in women with vulvodynia: a pilot study. J Gend Specif Med 2002;5:21-7.
22. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003;102:84-7.
23. Steinberg AC, Oyama IA, Rejba AE, Kellogg-Spadt S, Whitmore KE. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol 2005;192:1549-53.
24. Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999;89:1459-60.
25. Carlton SM, Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain 1998;76:201-7.
26. Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V. Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 2003;140:255-60.
27. Chen L, Goldman-Knaub J, Pullman-Mooar S. Local therapy for fibromyalgia and nonneuropathic pain. 1st ed. In: Wallace, DJ, Crauw DJ, editors. Fibromyalgia & other central pain syndromes. Philadelphia (PA): Lippincott Williams & Wilkins; 2005; p. 353-68.
28. Wilton LV, Shakir S. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia 2002;43:983-92.